1

Hualan Biological Engineering

#2894

Rank

$4.45B

Marketcap

CN China

Country

Hualan Biological Engineering
Leadership team

Ms. Bei Fan (Exec. Deputy Gen. Mang. and Director)

Mr. Kang An (Chairman of Directors and Gen. Mang.)

Mr. Jun Min Xie (Chief Financial Officer and Sec. of the Board of Directors)

Products/ Services
Biopharma, Biotechnology, Medical Device, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Xinxiang, Henan, China
Established
1992
Net Income
100M - 500M
Revenue
500M - 1B
Traded as
002007.SZ
Overview
Location
Summary
Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People's Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company's vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine. The company has strategic alliance with the Chinese Academy of Sciences, and other scientific research institutes and scientific research companies. The company was founded in 1992 and is based in Xinxiang, the People's Republic of China.
History

Hualan was founded in 1986 by Chen Shihua. In the 1980s, Hualan began to specialize in the production of diagnostic reagents for the medical industry and was one of the first Chinese companies to do so. In the following years, Hualan continued to expand its operations, and by the early 2000s, the company had become a leading player in the Chinese healthcare industry. Today it is one of the country’s largest diagnostic reagent manufacturers, with a large customer base.

Mission
Hualan’s mission is to create a world-class healthcare system by providing innovative, reliable, and cost-effective diagnostic reagents to our customers.
Vision
Our vision is to be the global leader in the medical biotechnology industry by creating the best diagnostic reagents in the world.
Key Team

Ms. Ruo Wen Pan (Deputy Gen. Mang.)

Mr. Bao Xian Zhang (Deputy Gen. Mang.)

Mr. Xiao Wei Ma (Deputy Gen. Mang.)

Ms. Ying An (Exec. Director)

Mr. Qi Ping Wang (Deputy Gen. Mang. and Director)

Recognition and Awards
2018 Best Diagnostic Reagents Award from the Chinese Ministry of Health, 2017 Asia Pacific Biotechnology Innovation Award
References
Hualan Biological Engineering
Leadership team

Ms. Bei Fan (Exec. Deputy Gen. Mang. and Director)

Mr. Kang An (Chairman of Directors and Gen. Mang.)

Mr. Jun Min Xie (Chief Financial Officer and Sec. of the Board of Directors)

Products/ Services
Biopharma, Biotechnology, Medical Device, Pharmaceutical
Number of Employees
1,000 - 20,000
Headquarters
Xinxiang, Henan, China
Established
1992
Net Income
100M - 500M
Revenue
500M - 1B
Traded as
002007.SZ